Basel, Basel, Switzerland
A highly motivated scientist with 8 years of experience in pharmaceutical R&D, I possess both deep scientific expertise and proven project management skills. Specializing in oncology drug development, I have a successful track record leading imaging strategies for small and large molecule programs. My experience encompasses advanced imaging techniques like radiolabeled molecules and radiomics tools, alongside proficiency in standard and indication-specific response assessments for solid tumors and hematologic malignancies. Beyond technical capabilities, I excel in clinical trial management with iCROs, team leadership and collaboration, and fostering partnerships with academic and industry organizations.
Driving the development of novel targeted radiopharmaceutical treatments and implementing imaging strategies in clinical trials.
- Preclinical studies combining high-dose radiation therapy and cancer immunotherapy compounds - Developing new checkpoint inhibitor-based antibody tracers for non-invasive imaging of the PD-1/PD-L1 pathway using immunoPET imaging
Evaluating the role of the Iga/Igb subunits in B cell receptor signaling